Regenerative Aesthetics Brand aphranel® Showcased at MXGP Shanghai

aphranel®, a regenerative aesthetics brand developed in China by MOYOM Biotech, served as an official partner for the MXGP Shanghai 2026 event, held from September 11-13. The brand used the event to introduce its approach to facial aesthetics to a broader audience beyond the traditional medical aesthetics community.

The aphranel® exhibition space featured a design incorporating the brand's signature green color, complemented by butterfly and motorcycle installations that echoed the motorsports theme. A dedicated aphranel Time Café offered visitors an experience themed around "Be the master of your state. Dare to take the stage," which proved to be a popular photo opportunity during the race weekend.

Targeting the predominantly male audience at the event, aphranel® focused on male facial aesthetics. Their MagiCCrystal CaHA bio-stimulator is applied for anatomy-based facial contouring in areas such as the brow, nose, chin, and jawline. This aims to enhance facial proportions and structural definition while preserving individual characteristics.

MagiCCrystal is the result of a CaHA development program initiated by MOYOM Biotech in 2013, supported by China's National Science and Technology Project during the 13th Five-Year Plan. In February 2025, following 12 years of research and product development, MagiCCrystal received Class III medical device registration from China's NMPA, becoming the first approved calcium hydroxyapatite microsphere facial bio-stimulator in the country.

With accumulated sales exceeding 200,000 syringes and distribution through over 700 aesthetic clinics in China, aphranel® is pursuing international expansion. The collaboration with MXGP provided a platform to connect its long-term research and technical precision with values commonly associated with motorsports. The brand's philosophy, "Be With Time," aims to align scientific endeavors with evolving contemporary aesthetic perceptions.